| |
NCT group (n = 23)
|
FC group (n = 21)
|
FC-PCC group (n = 17)
|
P-values
|
|---|
| | |
FC-PCC versus NCT
|
FC-PCC versus FC
|
|---|
|
EXTEM
| | | |
|
CT, sec
|
58.2 ± 9.5
|
70.2 ± 21.6
|
72.6 ± 31.5
|
0.045
|
ns
|
|
CFT, sec
|
102.3 ± 29.9
|
116.0 (96.5 to 160.0)
|
123.0 (109.0 to 165.0)
|
0.001
|
ns
|
|
CA10, mm
|
55.2 ± 6.7
|
48.1 ± 7.8
|
46.3 ± 9.2
|
0.001
|
ns
|
|
FIBTEM
| | | |
|
CA10, mm
|
12.0 (10.0 to 15.0)
|
8.0 (7.0 to 12.5)
|
8.0 (4.3 to 11.8)
|
0.0094
|
ns
|
- CA10, clot amplitude after 10 minutes running time; CT, clotting time; CFT, clot formation time; EXTEM, extrinsically activated test; FIBTEM, extrinsically activated test plus cytochalasin D; NCT group, no coagulation therapy; FC group, fibrinogen concentrate only; FC-PCC group, prothrombin complex concentrate and fibrinogen concentrate. Data are presented as mean ± standard deviation or median (interquartile range).
-
P-values are derived from t-test or Mann-Whitney U-test; significance level P <0.05; ns, not significant.
